Content

x

Search in this site

Grenoble Institut des Neurosciences Grenoble Institut des Neurosciences

  • Linkedin
  • Twitter
  • Youtube

Home > About us > News

See the complete sitemap

The GREEN Project: GREnoble Excellence in Neurodegeneration awarded the “center of excellence” label

on the July 6, 2015
Research

The project, supported by several Grenoble laboratories, has been chosen as one of the French centers of excellence within the CoEN network

The GREEN project, supported by several Grenoble laboratories and research teams (GIN, Clinatec, TIMC-IMAG, IAB, etc.), and has been chosen as one of the French centers of excellence within the CoEN network (Centers of excellence in Neurodegeneration in Europe and Canada). As such, GREEN will have the opportunity to become a partner in the CoEN network’s call for proposals.

In April 2015, the Grenoble Institute of Neuroscience, in association with other Grenoble laboratories, tendered a “identify centers of excellence in neurodegenerative research” bid launched by the French National Alliance for Life Sciences and Health (AVIESAN). This call for tenders was part of the National Plan for Neurodegenerative Diseases (2014 2019) announced in November 2014 by the French Minister of Health. Six centers have been selected and identified as the French centers of excellence within the CoEN network (Centres of Excellence in Neurodegeneration in Europe and Canada).

Coordinated by Frédéric Saudou, the director of the GIN, the GREEN project: GREnoble Excellence in Neurodegeneration mainly focuses on Alzheimer’s disease, Parkinson’s disease and multiple sclerosis.

The aim of these Centers is to create and develop a continuum between basic, preclinical, translational and clinical research. These centers will also integrate innovative research in health technology and in humanities and social sciences on issues related to the onset of the diseases, cognitive and behavioral assessment, social and medical care, the social environment and the social cost of neurodegenerative diseases.

The centers will also contribute with their expertise to help establish better methods for diagnosis and improve the treatment of neurodegenerative diseases. Finally, these centers are committed to facilitating a faster transfer of knowledge and technology.

This label gives Grenoble researchers the opportunity to coordinate their actions more effectively on those three pathologies and to extend their activity to other neurodegenerative diseases.

For more information:
> www.coen.org
> www.aviesan.fr

 


Updated on November 2, 2016

Membres
Associés renforcés
Associés simples